Reata Pharma (RETA) Tops Q1 EPS by 51c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Reata Pharma (RETA) Tops Q1 EPS by 51c

Reata Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results and Provides an Update on Development Programs

May 11, 2020 4:01 PM EDT

PLANO, Texas, May 11, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (Reata, the Company, or we), a clinical-stage biopharmaceutical company, today announced financial results for the quarter ended March 31, 2020, and provided an update on the Companys business and product development programs.

Recent Company Highlights

Reata recently announced changes to its clinical programs and operations as a result of the COVID-19 pandemic.  For each clinical development program, Reata developed and implemented changes designed to mitigate risk to patients; comply with regulatory, institutional,... More